Literature DB >> 2222355

Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin.

J I Cochius1, R J Burns, P C Blumbergs, K Mack, C P Alderman.   

Abstract

A forty-year-old female presented with an unsteady gait 13 years after receiving an eight-month course of human pituitary-derived gonadotrophin injections as treatment for infertility. Over the next ten months the patient subsequently developed generalised myoclonic jerks and dementia and finally died. Neuropathological examination revealed changes in the brain consistent with Creutzfeldt-Jakob disease. This is the first reported case of Creutzfeldt-Jakob disease in a recipient of human derived gonadotrophin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2222355     DOI: 10.1111/j.1445-5994.1990.tb01322.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  16 in total

1.  Creutzfeldt-Jakob disease, new variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy - An update.

Authors:  J M Conly; S D Shafran
Journal:  Can J Infect Dis       Date:  1997-01

Review 2.  The spongiform encephalopathies.

Authors:  R G Will
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-09       Impact factor: 10.154

Review 3.  Etiology and pathogenesis of prion diseases.

Authors:  S J DeArmond; S B Prusiner
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

4.  Creutzfeldt-Jakob disease after pituitary gonadotrophins.

Authors:  D L Healy; J Evans
Journal:  BMJ       Date:  1993-08-28

5.  [Gonadotropins and infertility--a historical overview].

Authors:  B Lunenfeld
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

6.  Accidental transmission of Creutzfeldt-Jakob disease by dural cadaveric grafts.

Authors:  J F Martínez-Lage; M Poza; J Sola; J G Tortosa; P Brown; L Cervenáková; J A Esteban; A Mendoza
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-09       Impact factor: 10.154

7.  Recombinant follitropin alfa/lutropin alfa in fertility treatment.

Authors:  Ahmed Gibreel; Siladitya Bhattacharya
Journal:  Biologics       Date:  2010-02-04

8.  Early cognitive decline in Creutzfeldt-Jakob disease associated with human growth hormone treatment.

Authors:  R J Cordery; M Hall; L Cipolotti; S Al-Sarraj; D G O'Donovan; L Davidson; P Adlard; M N Rossor
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

9.  Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin: a second case.

Authors:  J I Cochius; N Hyman; M M Esiri
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

Review 10.  Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells.

Authors:  Leopold Grillberger; Thomas R Kreil; Sonia Nasr; Manfred Reiter
Journal:  Biotechnol J       Date:  2009-02       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.